CERULEAN PHARMA INC Chart calendar Cerulean Pharma Inc
b0c0491d065ea4bf05759ddc47b.mufH4UDgJnfJ1uwOvxyU-_rUlMBJMm1N0fd8kkZMZLU.6rX_onaMah2Gtbh93Gb3oruCoLpxQwwkvaQO6DR4K-r7lYigA9MfEqKY1A~8931234bccb20e67eaff5c99fcfdd25e
Upcoming events on Cerulean Pharma Inc
Past events on Cerulean Pharma Inc
| 2024-03-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-28 08:00 am | Q4 2023 Earnings Release |
| 2024-02-24 01:05 pm | Society for the Study of Women Sexual Health International Meeting - Impact of Enrollment Diagnosis |
| 2024-02-24 01:05 pm | Society for the Study of Women Sexual Health International Meeting - Sexual Experiences in an Explor |
| 2024-02-24 01:05 pm | Society for the Study of Women Sexual Health International Meeting - Female Sexual Distress in an Ex |
| 2023-11-18 04:30 pm | Sexual Medicine Society of North America Fall Scientific Meeting |
| 2023-11-14 04:45 pm | Stifel Healthcare Conference |
| 2023-11-10 12:00 pm | Collaborating for Novel Solutions Summit |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-09 08:00 am | Q3 2023 Earnings Release |
| 2023-09-30 09:35 am | North American Menopause Society Meeting - Study to Evaluate the Preliminary Efficacy and Usability |
| 2023-09-30 09:35 am | North American Menopause Society Meeting - Study to Evaluate the Safety and Pharmacokinetics |
| 2023-09-30 09:35 am | North American Menopause Society Meeting - Safety and Preliminary Pharmacodynamic Evaluation |
| 2023-09-26 09:20 am | Cantor Global Healthcare Conference |
| 2023-09-11 01:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-10 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-07-13 | International Symposium |
| 2023-07-11 04:30 pm | Investor Meeting - Key Opinion Leaders |
| 2023-06-21 12:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,65 - | 0,00 1,25 - | 10,0 10,0 0% | 2,81 2,12 32.62% | 5,43 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,3 -14,3 -0.46% | -27,4 -25,6 -7.05% | -39,1 -42,6 8.19% | -31,4 -25,9 -21.4% | -30,9 -34,3 9.74% | -30,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,3 -14,6 2.28% | -27,4 -25,6 -7.18% | -38,7 -41,2 5.99% | -30,9 -23,8 -29.94% | -30,2 -33,5 9.92% | -29,6 |
|
Net income Million USD | Released Forecast Spread | -15,1 -14,8 -1.82% | -27,4 -25,9 -6.01% | -38,7 -35,7 -8.39% | -30,9 -25,7 -20.37% | -30,2 -33,5 10% | -29,6 |
|
EPS USD | Released Forecast Spread | -0,97 -0,95 -2.37% | -0,91 -0,87 -5.2% | -0,63 -0,60 -5% | -0,37 -0,31 -21.31% | -0,35 -0,37 4.55% | -0,27 |
| Announcement Date | 27/03/20 | 30/03/21 | 31/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 1,25 - | 0,00 0,00 - | 10,0 6,67 50% | 0,00 2,65 - | 0,00 0,00 - | 0,00 2,50 - | 0,00 0,90 - | 1,00 0,39 159.29% | 1,81 1,45 24.63% | 0,52 | 3,07 | 0,59 | 4,19 |
|
EBIT Million USD | Released Forecast Spread | -9,54 -13,0 26.75% | -8,40 -12,5 32.53% | 0,38 -5,55 106.92% | -7,14 -9,84 27.42% | -16,2 -10,7 -51.7% | -8,38 -12,0 30.07% | -8,99 -7,97 -12.83% | -8,40 -8,90 5.68% | -5,17 -8,49 39.11% | -6,67 | -4,40 | -10,8 | -4,21 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,54 -11,9 19.7% | -8,40 -13,4 37.39% | 0,41 -8,71 104.75% | -7,02 -9,47 25.84% | -15,9 -8,76 -81.94% | -8,04 -12,0 32.91% | -8,76 -7,90 -10.91% | -8,30 -8,77 5.37% | -5,06 -8,38 39.62% | -6,37 | -4,17 | -10,7 | -3,91 |
|
Net income Million USD | Released Forecast Spread | -9,54 -13,0 26.75% | -8,40 -11,6 27.49% | 0,41 -5,55 107.46% | -7,02 -9,83 28.56% | -15,9 -10,7 -49.45% | -8,04 -12,0 32.91% | -8,76 -7,90 -10.91% | -8,30 -8,77 5.37% | -5,06 -8,38 39.62% | -6,37 | -4,17 | -10,7 | -3,91 |
|
EPS USD | Released Forecast Spread | -0,18 -0,18 0% | -0,10 -0,14 30.23% | 0,00 -0,06 107.74% | -0,08 -0,11 29.41% | -0,19 -0,13 -52% | -0,09 -0,10 10% | -0,10 -0,09 -11.11% | -0,09 -0,10 10% | -0,06 -0,08 25% | -0,06 | -0,04 | -0,09 | -0,03 |
| Announcement Date | 31/03/22 | 12/05/22 | 09/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
